Iridian Asset Management’s TherapeuticsMD TXMD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q4 | – | Sell |
-1,666
| Closed | -$62K | – | 76 |
|
2021
Q3 | $62K | Hold |
1,666
| – | – | ﹤0.01% | 72 |
|
2021
Q2 | $99K | Hold |
1,666
| – | – | ﹤0.01% | 92 |
|
2021
Q1 | $112K | Hold |
1,666
| – | – | ﹤0.01% | 103 |
|
2020
Q4 | $101K | Hold |
1,666
| – | – | ﹤0.01% | 78 |
|
2020
Q3 | $132K | Hold |
1,666
| – | – | ﹤0.01% | 74 |
|
2020
Q2 | $104K | Hold |
1,666
| – | – | ﹤0.01% | 69 |
|
2020
Q1 | $88K | Hold |
1,666
| – | – | ﹤0.01% | 69 |
|
2019
Q4 | $202K | Hold |
1,666
| – | – | ﹤0.01% | 73 |
|
2019
Q3 | $302K | Hold |
1,666
| – | – | ﹤0.01% | 69 |
|
2019
Q2 | $217K | Hold |
1,666
| – | – | ﹤0.01% | 71 |
|
2019
Q1 | $406K | Hold |
1,666
| – | – | 0.01% | 69 |
|
2018
Q4 | $317K | Hold |
1,666
| – | – | ﹤0.01% | 64 |
|
2018
Q3 | $546K | Buy |
1,666
+289
| +21% | +$94.7K | 0.01% | 66 |
|
2018
Q2 | $430K | Buy |
1,377
+233
| +20% | +$72.8K | ﹤0.01% | 71 |
|
2018
Q1 | $279K | Buy |
+1,144
| New | +$279K | ﹤0.01% | 77 |
|